Philippe Carassou

Ars-sur-moselle, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere

Published: November 26, 2025

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.

Journal: EClinicalMedicine

Published: July 30, 2025

Multiple Myeloma Presenting as Breast Metastasis: Diagnostic Challenges and Case Analysis.

Multiple Myeloma Presenting as Breast Metastasis: Diagnostic Challenges and Case Analysis.

Journal: The American journal of case reports

Published: April 24, 2025

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.

Journal: Blood advances

Published: December 20, 2022

A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Carcinoma and Disseminated Intravascular Coagulation.

A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Carcinoma and Disseminated Intravascular Coagulation.

Journal: The American journal of case reports

Published: March 05, 2021

A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.

A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.

Journal: Blood

Published: July 13, 2020

TAR syndrome: Clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A.

TAR syndrome: Clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A.

Journal: Human mutation

Published: November 13, 2019

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.

Journal: The Lancet. Haematology

Published: April 17, 2019

Cutaneous manifestations in blastic plasmacytoid cell neoplasm: About two cases

Cutaneous manifestations in blastic plasmacytoid cell neoplasm: About two cases

Journal: Presse medicale (Paris, France : 1983)

Published: October 05, 2014

Fever, weight loss and arthralgia in a 52-year-old woman

Fever, weight loss and arthralgia in a 52-year-old woman

Journal: La Revue de medecine interne

Published: July 05, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026